Business News


Ford Motor Co. (NYSE:F) Issues Three Safety Recalls In North America- Five Below, Inc. (NASDAQ:FIVE), Schlumberger Limited (NYSE:SLB)

Automaker, Ford Motor Co. (NYSE:F) released on Wednesday that it issued three safety recalls in North America that covers a total of

Tech News


Unexpected Moves in Focus: FirstEnergy Corp. (NYSE:FE), Bellatrix Exploration Ltd. (NYSE:BXE), BankUnited, Inc. (NYSE:BKU)

A subsidiary of FirstEnergy Corp. (NYSE:FE) [Trend Analysis] announced its Perry Nuclear Power Plant in Perry, Ohio, FirstEnergy Nuclear

General News

stock news

FuelCell Energy (NASDAQ:FCEL) Swings on Major Declaration- Golar LNG (NASDAQ:GLNG), FedEx (NYSE:FDX), Archer-Daniels-Midland (NYSE:ADM)

FuelCell Energy Inc (NASDAQ:FCEL) (Full FREE Analysis of FCEL And Be Sure To Notice The Intermediate Period) released its fourth quarter



Dominion Resources (NYSE:D) Swings on Declaration- Cablevision Systems (NYSE:CVC), GlaxoSmithKline (NYSE:GSK), Harris (NYSE:HRS)

Dominion Resources, Inc. (NYSE:D) released that its fourth quarter earnings of $0.84 a share, excluding non-recurring items. The firm



Hot Stocks In Focus: JinkoSolar Holding Co., Ltd. (NYSE:JKS), Citigroup (NYSE:C), Microsoft Corporation (NASDAQ:MSFT)

Solar module make, JinkoSolar Holding Co., Ltd. (NYSE:JKS) reported that its subsidiary JinkoSolar Power Co., Ltd. has signed a strategic



Johnson & Johnson (NYSE:JNJ) Under Pressure on New Entrance- Silvercorp Metals (NYSE:SVM), Medtronic (NYSE:MDT), The Charles Schwab (NYSE:SCHW)

Johnson & Johnson (NYSE:JNJ) dropped around 2% in last session as Janssen Pharma declared that it will invest in a novel scientific approach, called disease interception, to find ways to intercept type 1 diabetes using new diagnostic and pre-disease intervention strategies. This new approach to T1D is the initial in a series of disease areas to be tackled as part of Janssen's newly announced Disease Interception Accelerator, an autonomous incubator-like group that seeks to identify the root causes of disease and enable the development of interventions that stop the progression to disease. Whereas, shares of Johnson & Johnson (NYSE:JNJ) traded down of -1.93% to finished at USD98.44 with market capitalization